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Transplantation of the liver has progressed in recent years and has become universally accepted for numerous indications of end-stage liver diseases, predominantly cirrhosis induced by viral hepatitis (HBV/HCV), acute hepatic failure and primary biliary cirrhosis. Interdisciplinary research is devoted to prevention of recurrent disease: Risk groups have been defined, in which HBV recurrence can be prevented by immunoprophylaxis. The risk of tumor recurrence can be calculated, adjuvant chemotherapy might improve prognosis of patients with small incidental tumors.